ABPI (Association of the British Pharmaceutical Industry) - Articles and news items

UK life sciences sector productivity double national average

Industry news / 7 March 2017 / Steve Bremer, Managing Editor

The PwC report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British In Vitro Diagnostics Association (BIVDA), shows that the average productivity of UK life sciences employees, expressed as gross value added (GVA), is £104,000, compared to the UK average of £49,000.

Pharmaceutical industry to pay £550 million in 2016 as part of the PPRS

Industry news / 22 December 2015 / Victoria White

The PPRS is a unique scheme where pharmaceutical companies agreed to contribute towards the cost of medicines, with the aim of making the latest treatments affordable for the NHS…


ABPI and OBN announce Memorandum of Understanding

Industry news / 13 October 2014 / ABPI and OBN

The ABPI, which represents large, medium and small innovative research-based biopharmaceutical companies in the UK and OBN, the membership organisation that brings together the UK’s emerging life sciences companies, corporate partners and investors are delighted to announce their commitment to working together under a Memorandum of Understanding…


Sanofi to expand access to Clinical Trial Data

Industry news / 2 January 2014 / Sanofi

“Sanofi has a history of contributing in this collective effort of sharing clinical trial data and results with researchers and patients with initiatives such as Project Data Sphere…”

New carbon footprint tool launched to calculate the carbon footprint of pharmaceutical products

Industry news, News / 28 August 2013 / Carbon Trust

ABPI collaborates with the Carbon Trust to help pharmaceutical companies quickly estimate the carbon footprint of tablet medicines distributed in blister packs…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...